T0	Disease 124 127	PCa
#1	AnnotatorNotes T0	DOID:10283
T1	Chemical 154 165	nucleotides
T11	Disease 721 751	de novo acute myeloid leukemia
#3	AnnotatorNotes T11	DOID:9119
T13	Disease 768 780	solid tumors
#5	AnnotatorNotes T13	DOID:162
T15	Disease 847 853	cancer
T16	Disease 909 936	stage II/III gastric cancer
#7	AnnotatorNotes T16	not found, not found
T19	Disease 1141 1144	PCa
T22	Disease 1274 1277	PCa
T4	Disease 287 311	autism spectrum disorder
#12	AnnotatorNotes T4	DOID:0060041
T5	Disease 391 396	tumor
#13	AnnotatorNotes T5	DOID:162
T6	RNA-Noncoding 437 443	NAP1L6
T7	Disease 499 502	PCa
T8	Disease 590 596	cancer
#16	AnnotatorNotes T8	DOID:162
T3	RNA-Noncoding 114 120	NAP1L6
#2	AnnotatorNotes T3	HGNC:31706
T10	Biomarker 107 120	lncRNA NAP1L6
R1	Association Arg1:T10 Arg2:T0	
T14	RNA-Noncoding 129 135	NAP1L6
T2	Biomarker 233 264	copy number variation of NAP1L6
T18	Biomarker 437 443	NAP1L6
R3	Association Arg1:T18 Arg2:T7	
T20	Gene-Protein 541 546	INHBA
#9	AnnotatorNotes T20	HGNC:6066
T21	Gene-Protein 678 683	INHBA
T23	Gene-Protein 782 787	INHBA
T17	Gene-Protein 1060 1065	INHBA
T24	Gene-Protein 1146 1151	INHBA
T25	Gene-Protein 1252 1257	INHBA
T9	Biomarker 1146 1182	INHBA was found to be over-expressed
R4	Association Arg1:T9 Arg2:T19	
T26	Biomarker 659 683	high expression of INHBA
R5	Prognostic-Poor Arg1:T26 Arg2:T11	
T27	RNA-Noncoding 258 264	NAP1L6
T28	Gene-Protein 581 586	INHBA
T12	Biomarker 782 842	INHBA expression levels were found to be significantly highe
T29	Drug-Class 950 971	adjuvant chemotherapy
T30	Biomarker 1055 1076	high INHBA expression
T31	Biomarker 1252 1257	INHBA
R8	Association Arg1:T31 Arg2:T22	
R9	Prognostic-Poor Arg1:T30 Arg2:T16	
T32	Drug-Class 977 980	S-1
T33	Biomarker 558 586	regulative function of INHBA
R10	Association Arg1:T33 Arg2:T8	
R2	Association Arg1:T12 Arg2:T34	
T34	Collection 847 936	cancer tissue than in adjacent normal mucosa in patients with stage II/III gastric cancer
